BDBM609529 7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)-4-methyl-N—((R)-1-(2-methyl-3-(trifluoromethyl)phenyl)ethyl)pyrido[3,4-d]pyridazin-1-amine::US11702418, Example 12-2

SMILES C[C@@H](Nc1nnc(C)c2cnc(cc12)N1CC2CC(C1)O2)c1cccc(c1C)C(F)(F)F

InChI Key InChIKey=IWYZSIJSMYUQIX-UHFFFAOYSA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 609529   

TargetSon of sevenless homolog 1 [564-1049]()
Mirati Therapeutics

US Patent
LigandPNGBDBM609529(US11702418, Example 12-2 | 7-(6-oxa-3-azabicyclo[3...)
Affinity DataIC50: 9nMAssay Description:Table 24: This Example illustrates that exemplary compounds of the present invention prevent KRas-mediated GTP nucleotide exchange mediated by SOS1 t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2023
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1 [564-1049]()
Mirati Therapeutics

US Patent
LigandPNGBDBM609529(US11702418, Example 12-2 | 7-(6-oxa-3-azabicyclo[3...)
Affinity DataKi:  0.600nMAssay Description:Table 22: This Example illustrates that exemplary compounds of the present invention bind to SOS1 and prevent a labeled tracer ligand from occupying ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2023
Entry Details
Go to US Patent